Health ❯ Healthcare ❯ Vaccines ❯ Influenza Vaccines

mRNA Vaccines

Pfizer’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

Regulatory uncertainty now determines whether the candidate advances to U.S. authorization.

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial